Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Gabapentin Market, by Application
1.4.2 LAMEA Gabapentin Market, by Dosage Form
1.4.3 LAMEA Gabapentin Market, by Distribution Channel
1.4.4 LAMEA Gabapentin Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. LAMEA Gabapentin Market by Application
3.1 LAMEA Epilepsy Market by Country
3.2 LAMEA Restless Legs Syndrome Market by Country
3.3 LAMEA Neuropathic Pain Market by Country
3.4 LAMEA Others Market by Country
Chapter 4. LAMEA Gabapentin Market by Dosage Form
4.1 LAMEA Capsule Market by Country
4.2 LAMEA Tablet Market by Country
4.3 LAMEA Oral Solution Market by Country
Chapter 5. LAMEA Gabapentin Market by Distribution Channel
5.1 LAMEA Hospital Pharmacy Market by Country
5.2 LAMEA Retail Pharmacy Market by Country
5.3 LAMEA Online Pharmacy Market by Country
Chapter 6. LAMEA Gabapentin Market by Country
6.1 Brazil Gabapentin Market
6.1.1 Brazil Gabapentin Market by Application
6.1.2 Brazil Gabapentin Market by Dosage Form
6.1.3 Brazil Gabapentin Market by Distribution Channel
6.2 Argentina Gabapentin Market
6.2.1 Argentina Gabapentin Market by Application
6.2.2 Argentina Gabapentin Market by Dosage Form
6.2.3 Argentina Gabapentin Market by Distribution Channel
6.3 UAE Gabapentin Market
6.3.1 UAE Gabapentin Market by Application
6.3.2 UAE Gabapentin Market by Dosage Form
6.3.3 UAE Gabapentin Market by Distribution Channel
6.4 Saudi Arabia Gabapentin Market
6.4.1 Saudi Arabia Gabapentin Market by Application
6.4.2 Saudi Arabia Gabapentin Market by Dosage Form
6.4.3 Saudi Arabia Gabapentin Market by Distribution Channel
6.5 South Africa Gabapentin Market
6.5.1 South Africa Gabapentin Market by Application
6.5.2 South Africa Gabapentin Market by Dosage Form
6.5.3 South Africa Gabapentin Market by Distribution Channel
6.6 Nigeria Gabapentin Market
6.6.1 Nigeria Gabapentin Market by Application
6.6.2 Nigeria Gabapentin Market by Dosage Form
6.6.3 Nigeria Gabapentin Market by Distribution Channel
6.7 Rest of LAMEA Gabapentin Market
6.7.1 Rest of LAMEA Gabapentin Market by Application
6.7.2 Rest of LAMEA Gabapentin Market by Dosage Form
6.7.3 Rest of LAMEA Gabapentin Market by Distribution Channel
Chapter 7. Company Profiles
7.1 Zydus Lifesciences Ltd.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Trials and approvals:
7.2 Glenmark Pharmaceuticals Limited
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expenses
7.3 Pfizer, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional & Segmental Analysis
7.3.4 Research & Development Expense
7.4 Sun Pharmaceutical Industries Ltd.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 Recent strategies and developments:
7.4.5.1 Acquisition and Mergers:
7.5 Alkem Laboratories Ltd.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional Analysis
7.5.4 Research & Development Expenses
7.6 Teva Pharmaceutical Industries Ltd.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 Recent strategies and developments:
7.6.5.1 Partnerships, Collaborations, and Agreements:
7.7 Aurobindo Pharma Limited
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expense
7.8 Amneal Pharmaceuticals, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental Analysis
7.8.4 Research & Development Expenses
7.9 Cipla Limited
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Regional Analysis
7.9.4 Research & Development Expense
7.10. Apotex, Inc.
7.10.1 Company Overview
Unique Offerings 